Sociedad Americana de Hirudoterapia

Large scale changes in the transcriptome of Eisenia fetida during regeneration

Research article published in PloS one (2018)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Observational studyGenómica y proteómicaBhambri A et al. · PloS one, 2018

Abstract

Earthworms show a wide spectrum of regenerative potential with certain species like Eisenia fetida capable of regenerating more than two-thirds of their body while other closely related species, such as Paranais litoralis seem to have lost this ability. Earthworms belong to the phylum Annelida, in which the genomes of the marine oligochaete Capitella telata and the freshwater leech Helobdella robusta have been sequenced and studied. Herein, we report the transcriptomic changes in Eisenia fetida (Indian isolate) during regeneration. Following injury, E. fetida regenerates the posterior segments in a time spanning several weeks. We analyzed gene expression changes both in the newly regenerating cells and in the adjacent tissue, at early (15days post amputation), intermediate (20days post amputation) and late (30 days post amputation) by RNAseq based de novo assembly and comparison of transcriptomes. We also generated a draft genome sequence of this terrestrial red worm using short reads and mate-pair reads. An in-depth analysis of the miRNome of the worm showed that many miRNA gene families have undergone extensive duplications. Sox4, a master regulator of TGF-beta mediated epithelial-mesenchymal transition was induced in the newly regenerated tissue. Genes for several proteins such as sialidases and neurotrophins were identified amongst the differentially expressed transcripts. The regeneration of the ventral nerve cord was also accompanied by the induction of nerve growth factor and neurofilament genes. We identified 315 novel differentially expressed transcripts in the transcriptome, that have no homolog in any other species. Surprisingly, 82% of these novel differentially expressed transcripts showed poor potential for coding proteins, suggesting that novel ncRNAs may play a critical role in regeneration of earthworm.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsEvolution, MolecularGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksGenomeMicroRNAsMultigene FamilyOligochaetaPhylogenyRegenerationSOXC Transcription Factors

Resumen

Large scale changes in the transcriptome of Eisenia fetida during regeneration.

Por qué esto importa para la hirudoterapia

Este estudio analizó los cambios transcriptómicos a gran escala durante la regeneración del segmento posterior en la lombriz de tierra Eisenia fetida tras la amputación. Los investigadores utilizaron RNAseq para identificar genes diferencialmente expresados, incluyendo reguladores maestros de la transición epitelio-mesénquima y nuevos ARN no codificantes, al tiempo que generaron una secuencia de genoma borrador para el gusano. Aunque el resumen menciona el genoma de la sanguijuela de agua dulce Helobdella robusta como referencia genómica comparativa dentro del filo Annelida, el estudio en sí no involucra sanguijuelas. En consecuencia, esta investigación es completamente irrelevante para la hirudoterapia, y no ofrece datos sobre la biología de la sanguijuela, el secretoma de la sanguijuela ni ninguna aplicación terapéutica.

Citación

Large scale changes in the transcriptome of Eisenia fetida during regeneration

Bhambri A et al. · PloS one, 2018

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.